Among real-world US patients with mCSPC, apalutamide users achieved PSA90 response approximately 5 months earlier than abiraterone users, with more achieving deeper PSA decline. A real-world analysis ...

Researchers present consensus statement for core competencies to guide education for medical students on medical cannabis use.

Testosterone replacement therapy (TRT) in men with secondary hypogonadism due to nonfunctioning pituitary adenomas or prolactinomas is associated with a significantly lower risk of major adverse ...

Clinicians from Fox Chase Cancer Center at Temple University Health share their highlights from the Society of Urologic ...

The addition of RARP to ADT significantly increased the rate of achieving radical level PSA levels (74.7% vs 38.3%; P <.001) and a shorter time to PSA nadir (2 vs 6 months; P <.001) compared with ADT ...

Five diabetes subgroups (MARD, MOD, SAID, SIDD, SIRD) have specific comorbidity and mortality risk profiles, study results show.

Researchers identified 8 immune cell phenotypes that demonstrated causal associations with gout risk: 5 protective and 3 linked to increased risk. Interactions between immune cell phenotypes and gut ...

MRI is the ideal imaging modality for initial evaluation and diagnosis of testicular cancer.

Once-weekly tirzepatide is associated with clinically relevant reductions in SUA levels over 72 weeks, largely driven by substantial weight loss.

GLP-1 RA therapy linked to significantly lower risk for epilepsy compared with DPP4-i use among adults with T2DM.